PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ferriprotinate→

Ferriprotinate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
Not available
Molecular formula
Not available
Molecular weight
Not available
Drug class
Iron replacement complexferric protein succinylate preparation
Mechanism of action
A ferric iron-protein complex designed to deliver iron for gastrointestinal absorption. After digestion and dissociation of the protein complex, iron is made available for transfer and incorporation into haemoglobin and iron stores. The exact pharmacokinetics and elemental iron content are product-specific.
Indications / reported uses
  • Oral treatment of iron deficiency and iron-deficiency anaemia in countries where ferric protein succinylate products are authorised.

Sources: https://pubchem.ncbi.nlm.nih.gov/#query=ferric%20protein%20succinylate · https://www.ncbi.nlm.nih.gov/mesh/?term=ferric+protein+succinylate · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ferriprotinate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferriprotinate Permitted Daily Exposure (PDE) report (the Ferriprotinate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferriprotinate Occupational Exposure Limit (OEL) report (the Ferriprotinate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.